| AKT | protein kinase B |
| ALN-oHA-S-S-CU | poly-alendronate-ialuronane-S-S-curcumin |
| BMD | bone mineral density |
| CGF | Concentrated Growth Factors |
| CTX | C-Terminal Telopeptide |
| CU | Curcumin |
| CU-NPr | nanoparticles coated with curcumin |
| CU-Lip | Curcumin-loaded liposomes |
| DK1 | (Z)-3-hydroxy-1-(2-hydroxyphenyl)-3-phenylprop-2-en-1-one |
| DNMT1 | DNA Methyltransferase 1 |
| e-hPDLSC | endothelial-differentiated hPDLSC |
| ECM | extracellular matrix |
| FDA | Food and Drug Administration |
| GRAS | General Recognition and Safety |
| GUSB | β-glucuronidase |
| hADSCs | human adipose-derived mesenchymal stem cells |
| hBM-MSCs | mesenchymal stem cells derived from human bone marrow |
| hPDLSC | Human Periodontal Ligament Stem Cell |
| hUC-MSC | Human Umbilical Cord- derived Stem cell |
| L48H37 | 1-ethyl-3,5-bis((E)-3,4,5-trimethoxybenzylidene)piperidin-4-one |
| LPS-G | Lipopolysaccaride obtained from Porphyromonas gingivalis |
| MSC | Mesenchymal Stem Cell |
| NFkB | Nuclear factor kappa light chain enhancer of activated B cells |
| NLRP3 | NLR Family Pyrin Domain Containing 3 |
| NS-J | combination of CU, ginger, vitamin D, L. rhamnosus, and Boswellia extract |
| OB | osteoblasts |
| OP | osteoporosis |
| OPG | osteoprotegerin |
| OS | Osteosarcoma |
| PAO1 | Pseudomonas Aeruginosa |
| PFs | phenolic compounds |
| PI3K | Phosphatidylinossitol-3-kinase |
| PLA | Poly DL-lactic acid |
| PM | postemenopausal |
| PVL | Panton-Valentine Leukocidin toxin |
| Q | Quercetin |
| RANKL | RANK Ligand |
| RCT | randomised control trial |
| ROS | Reactive Oxygen Species |
| RSV | Resveratrol |
| SIRT1 | Activates Sirtuin 1 |
| TLR4 | Tool-like receptor 4 |
| TNF | Tumour Necrosis Factor |
| [25(OH)D] | 25 vitamin D hydroxylase |